Polyrizon Ltd. 已正式宣布,其将与Eurofins CDMO Amatsiaquitaine S.a.s合作,启动符合药品生产质量管理规范(GMP)的临床实验材料(CTM)生产工作。此项生产旨在为该公司计划在美国开展的临床研究提供所需材料。
Polyrizon Ltd. 已正式宣布,其将与Eurofins CDMO Amatsiaquitaine S.a.s合作,启动符合药品生产质量管理规范(GMP)的临床实验材料(CTM)生产工作。此项生产旨在为该公司计划在美国开展的临床研究提供所需材料。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.